secwatch.observer — SEC 8-K summary
======================================

Issuer:     Design Therapeutics, Inc. (DSGN)
CIK:        0001807120
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0000950170-25-085380
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Design Therapeutics stockholders elect directors and ratify auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- Heather Berger, Ph.D., Rodney Lappe, Ph.D., and John Schmid elected as Class I directors to serve until 2028 annual meeting.
- Rodney Lappe received 32,799,677 votes for, 9,948,461 withheld, indicating notable opposition.
- Ernst & Young LLP ratified as independent auditor for FY2025 with 53,577,053 votes for, 2,731 against, 1,795 abstentions.
- A total of 56,768,678 shares were outstanding and entitled to vote as of the April 15, 2025 record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1807120/000095017025085380/0000950170-25-085380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1807120/000095017025085380/dsgn-20250610.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-085380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer